Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Parkinson's Disease

  Free Subscription


15.07.2019

1 Ann Neurol
1 Brain Res
2 J Neural Transm (Vienna)
1 J Neurochem
4 Mov Disord
1 Neurobiol Dis
3 Neurology
1 Neurosci Lett


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Neurol

  1. DEL DIN S, Elshehabi M, Galna B, Hobert M, et al
    Gait analysis with wearables predicts conversion to Parkinson's disease.
    Ann Neurol. 2019 Jul 11. doi: 10.1002/ana.25548.
    PubMed     Text format     Abstract available


    Brain Res

  2. JIANG Y, Liu J, Chen L, Jin Y, et al
    Serum secreted miR-137-containing exosomes affects oxidative stress of neurons by regulating OXR1 in Parkinson's disease.
    Brain Res. 2019 Jul 10:146331. doi: 10.1016/j.brainres.2019.146331.
    PubMed     Text format     Abstract available


    J Neural Transm (Vienna)

  3. DOS SANTOS AB, Bezerra MA, Rocha ME, Barreto GE, et al
    Higher zinc concentrations in hair of Parkinson's disease are associated with psychotic complications and depression.
    J Neural Transm (Vienna). 2019 Jul 11. pii: 10.1007/s00702-019-02041.
    PubMed     Text format     Abstract available

  4. BARBOSA RP, Mendonca MD, Caetano AP, Lampreia TM, et al
    Cognitive complaints in Parkinson's disease patients: from subjective cognitive complaints to dementia and affective disorders.
    J Neural Transm (Vienna). 2019 Jul 5. pii: 10.1007/s00702-019-02042.
    PubMed     Text format     Abstract available


    J Neurochem

  5. VIDYADHARA DJ, Lee JE, Chandra SS
    Role of the Endolysosomal System in Parkinson's disease.
    J Neurochem. 2019 Jul 9. doi: 10.1111/jnc.14820.
    PubMed     Text format     Abstract available


    Mov Disord

  6. KELLY MJ, Lawton MA, Baig F, Ruffmann C, et al
    Predictors of motor complications in early Parkinson's disease: A prospective cohort study.
    Mov Disord. 2019 Jul 8. doi: 10.1002/mds.27783.
    PubMed     Text format     Abstract available

  7. OERTEL WH, Henrich MT, Janzen A, Geibl FF, et al
    The locus coeruleus: Another vulnerability target in Parkinson's disease.
    Mov Disord. 2019 Jul 10. doi: 10.1002/mds.27785.
    PubMed     Text format    

  8. EVERS LJW, Krijthe JH, Meinders MJ, Bloem BR, et al
    Measuring Parkinson's disease over time: The real-world within-subject reliability of the MDS-UPDRS.
    Mov Disord. 2019 Jul 10. doi: 10.1002/mds.27790.
    PubMed     Text format     Abstract available

  9. MOOSA S, Martinez-Fernandez R, Elias WJ, Del Alamo M, et al
    The role of high-intensity focused ultrasound as a symptomatic treatment for Parkinson's disease.
    Mov Disord. 2019 Jul 10. doi: 10.1002/mds.27779.
    PubMed     Text format     Abstract available


    Neurobiol Dis

  10. CICCHETTI F, David LS, Siddu A, Denis HL, et al
    Cysteamine as a novel disease-modifying compound for Parkinson's disease: Over a decade of research supporting a clinical trial.
    Neurobiol Dis. 2019 Jul 10:104530. doi: 10.1016/j.nbd.2019.104530.
    PubMed     Text format     Abstract available


    Neurology

  11. LENKA A, Pagonabarraga J, Pal PK, Bejr-Kasem H, et al
    Minor hallucinations in Parkinson disease: A subtle symptom with major clinical implications.
    Neurology. 2019 Jul 9. pii: WNL.0000000000007913.
    PubMed     Text format     Abstract available

  12. LEE MJ, Pak K, Kim JH, Kim YJ, et al
    Effect of polygenic load on striatal dopaminergic deterioration in Parkinson disease.
    Neurology. 2019 Jul 9. pii: WNL.0000000000007939.
    PubMed     Text format     Abstract available

  13. BARICHELLA M, Cereda E, Pinelli G, Iorio L, et al
    Muscle-targeted nutritional support for rehabilitation in patients with parkinsonian syndrome.
    Neurology. 2019 Jul 5. pii: WNL.0000000000007858.
    PubMed     Text format     Abstract available


    Neurosci Lett

  14. HU F, Duan M, Peng N
    Knockdown of TRB3 improved the MPP(+)/MPTP-induced Parkinson's disease through the MAPK and AKT signaling pathways.
    Neurosci Lett. 2019;709:134352.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: